◆ AI Clinical Summary
Plain-language summary for patients
Trial Parameters
ConditionFrailty
SponsorUniversity of Thessaly
Study TypeOBSERVATIONAL
PhaseN/A
Enrollment200
SexALL
Min Age65 Years
Max AgeN/A
Start Date2023-04-01
Completion2025-12-31
All Conditions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
We ought to investigate if hip fracture patients suffering from frailty have higher inflammatory burden according to simple inflammatory biomarkers.
Eligibility Criteria
Inclusion Criteria: * age \>65 years, ASA PS I-III, non- institutionalized, able to communicate patients Exclusion Criteria: * Patients with severe cognitive dysfunction, those treated conservatively, those with pathological fractures and patients who refused to participate
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology